Ivermectin Inhibits Zika Virus Replication in Vitro But Does Not Prevent Zika Virus Infection in Rhesus Macaques (Macaca mulatta) (2025)

Peer-Reviewed Study · Cotrone TS, Kobylinski K, Ponlawat A, Im-Erbsin R, Sunyakumthorn P, Vanachayangkul P, et al. (12 authors) · March 2025

Cotrone TS et al., 2025-03: Zika study in cells, rhesus macaques and mosquitoes: ivermectin inhibited Zika replication in cell culture at 4-21 micromolar, but high-dose prophylaxis did not prevent infection in macaques or reduce virus in mosquitoes, though it killed the mosquitoes.

showed no reduction in ZIKV replication in mosquitoes. However, mosquito survival rates were significantly (P <0.0001) lower after exposure to ivermectin, thereby potentially impacting ZIKV transmission through increased vector mortality.

Cotrone TS et al., 2025-03: Zika study in cells, rhesus macaques and mosquitoes: ivermectin inhibited Zika replication in cell culture at 4-21 micromolar, but high-dose prophylaxis did not prevent infection in macaques or reduce virus in mosquitoes, though it killed the mosquitoes. In vitro cell culture (LLC-MK2 mammalian and C6/36 mosquito cells) plus in vivo rhesus macaque and Aedes aegypti experiments; no human subjects; United States (WRAIR). IC50 4.0-21.3 micromolar depending on cell line and genotype; high-dose ivermectin prophylaxis at 1.2 mg/kg for 3 consecutive days failed to prevent Zika infection in macaques and did not alter Zika IgM production. Disclosures: material reviewed by the Walter Reed Army Institute of Research, no objection to publication. Bearing CONTRADICTS the claim that ivermectin is an antiviral of clinical use against Zika, while confirming the in-vitro signal and a vector-mortality effect. Study type: animal.